Compass Pathways' delayed phase 3 readout for its psilocybin treatment has hit its primary endpoint of reducing the severity of patients’ depression, but investors appear unimpressed. The study ...
Fintel reports that on December 16, 2025, Compass Point initiated coverage of WhiteFiber (NasdaqCM:WYFI) with a Buy recommendation. Analyst Price Forecast Suggests 146.45% Upside As of December 6, ...
When a business leader or a college president writes about a strategic plan, I understand the temptation to turn the page. After all, what happens internally in most institutions has little impact on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback